Brett I. W. Zbar - 30 Jun 2022 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Director
Signature
/s/ Marella Thorell, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
30 Jun 2022
Net transactions value
$0
Form type
4
Filing time
05 Jul 2022, 19:00:19 UTC
Previous filing
06 Jul 2021
Next filing
23 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTA Share Option (right to buy) Award $0 +48,000 $0.000000 48,000 30 Jun 2022 Ordinary Shares 48,000 $4.87 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares subject to such Share Option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the next annual meeting of the issuer's shareholders, subject to continued service as a director through the applicable vesting date.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F3 The Share Option granted to Dr. Zbar is held by him solely for the benefit of General Atlantic Service Company, L.P. Dr. Zbar disclaims beneficial ownership of the Share Options and the underlying Ordinary Shares, except to the extent of his pecuniary interest therein, if any.